MARTIUS advises on the acquisition of Arkopharma Group from private equity company Montagu and minority shareholders by Dermapharm

MARTIUS regularly advises Dermapharm on its acquisitions and investments in Germany and abroad, as most recently in the acquisition of the German C3 Group, a group of companies specializing in the distribution of pharmaceutical cannabinoids, from the Canadian Canopy Growth Corporation for a purchase price of approximately €80 million.

Arkopharma is a leading supplier of herbal OTC products and dietary supplements in France and other European countries. In fiscal 2021, the Arkopharma Group generated sales of approximately €191 million. For the current fiscal 2022, it forecasts sales of just over €200 million.

With the Arkopharma Group, Dermapharm gains access to the French market and at the same time strengthens its presence in Spain, Italy, Portugal, Belgium and the Netherlands. Arkopharma distributes natural OTC products and nutritional supplements through direct sales locations and through partner networks in more than 30 countries.

Munich partners Dr. Philipp Kopp (Lead), Dr. Carsten Albert, Philipp Opitz provided comprehensive legal advice to Dermapharm.

Rocan Rechtsanwälte (Düsseldorf) with Dr. Timo Angerbauer (Partner) and Dr. Tobias Pukropski (Partner) acted for Dermapharm in terms of antitrust law.

MARTIUS also coordinated the following international advisors in France, Spain, Italy and Belgium:

Bredin Prat (Paris): José Maria Perez (Partner), Adrien Simon (Partner), Vianney Guillet de Chatellus (Associate), Thomas Beulaygue (Associate)

EY (Paris, Due Diligence in France, Italy and Belgium): Jean-Christophe Sabourin, Laurent-Paul Tour, Olivier Chapalain, Taïna Célestin, Matteo Zapelli, Giuseppe Vacchiano, Virginie Ciers, Jonathan De Landsheere, Guillaume Talneau, Nancy Bonasera, Ulberto Durelli, Barbara François, Marie-Emilie Truyens

Araoz & Rueda (Madrid, Due Diligence in Spain): Alejandro Fernández de Araoz (Partner), Luis Trigueros und José A. Escudero (Associates)

Point of contact

Dr. Carsten Albert Dr. Philipp Kopp Philipp Opitz

back